Hematology NewsAdding bortezomib to R-CHOP didn’t improve survival in diffuse large B-cell lymphomaSeptember 29, 2017Aggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Oncology PracticeProposed MACRA participation threshold gets mixed reviewsSeptember 29, 2017Practice ManagementBusiness of Medicine
Hematology TimesMaintenance will be a new standard in MCL, doc saysSeptember 29, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesDrugs could improve treatment of CMLSeptember 29, 2017Leukemia, Myelodysplasia, TransplantationCML
Oncology PracticeCheckmate 214: Upfront nivo/ipi bests TKI in advanced RCCSeptember 28, 2017Renal Cell CarcinomaImmunotherapyImmuno-oncology
Oncology PracticeFDA approves abemaciclib for advanced breast cancerSeptember 28, 2017Breast CancerMetastatic Breast Cancer
Oncology PracticeHER2 status differed between primary tumor and CTCs in 18.8% of women with MBCSeptember 28, 2017Breast CancerMetastatic Breast Cancer
The Journal of Community and Supportive OncologyTwo cases of possible remission in metastatic triple-negative breast cancerSeptember 28, 2017Breast CancerPatient & Survivor Care
Hospital Physician: Hematology/OncologyAdvanced Stage and Relapsed/Refractory Hodgkin LymphomaSeptember 28, 2017Lymphoma & Plasma Cell Disorders
Hematology TimesDaratumumab combos approved to treat MM in JapanSeptember 28, 2017Multiple MyelomaPharmacy
Hematology TimesFDA grants factor IX therapy orphan designationSeptember 28, 2017ThrombosisBleeding Disorders
